The global Resorbable Embolization Microspheres market size is predicted to grow from US$ 524 million in 2025 to US$ 997 million in 2031; it is expected to grow at a CAGR of 11.3% from 2025 to 2031.

Resorbable embolization microspheres are biodegradable medical devices used in minimally invasive procedures to block blood flow to targeted tissues, such as tumors or arteriovenous malformations. These microspheres are typically made from biocompatible materials like polylactic acid (PLA) or gelatin, designed to degrade safely within the body over time. Delivered via a catheter into the blood vessels, they provide temporary occlusion, allowing for localized treatment while minimizing damage to surrounding tissues. Resorbable embolization microspheres are widely used in interventional radiology for conditions like uterine fibroids, liver tumors, and post-traumatic bleeding, offering effective, targeted therapy with reduced long-term complications.

United States market for Resorbable Embolization Microspheres is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Resorbable Embolization Microspheres is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Resorbable Embolization Microspheres is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Resorbable Embolization Microspheres players cover Merit Medical Systems, Medtronic, Boston Scientific, Terumo, Sirtex Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Resorbable Embolization Microspheres Industry Forecast” looks at past sales and reviews total world Resorbable Embolization Microspheres sales in 2024, providing a comprehensive analysis by region and market sector of projected Resorbable Embolization Microspheres sales for 2025 through 2031. With Resorbable Embolization Microspheres sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Resorbable Embolization Microspheres industry.

This Insight Report provides a comprehensive analysis of the global Resorbable Embolization Microspheres landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Resorbable Embolization Microspheres portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Resorbable Embolization Microspheres market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Resorbable Embolization Microspheres and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Resorbable Embolization Microspheres.

This report presents a comprehensive overview, market shares, and growth opportunities of Resorbable Embolization Microspheres market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Polyvinyl Alcohol (PVA) Microspheres
    Trisacryl Gelatin Microspheres
    Others

Segmentation by Application:

    Uterine Fibroid Embolization (UFE)
    Liver Tumor Embolization
    Arteriovenous Malformation (AVM) Embolization
    Hemorrhage Control
    Others

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Merit Medical Systems
    Medtronic
    Boston Scientific
    Terumo
    Sirtex Medical
    ABK Biomedical
    BTG Medical
    Cook Medical
    Teleflex
    Nexsphere
    Penumbra
    Varian

Key Questions Addressed in this Report

What is the 10-year outlook for the global Resorbable Embolization Microspheres market?
What factors are driving Resorbable Embolization Microspheres market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Resorbable Embolization Microspheres market opportunities vary by end market size?
How does Resorbable Embolization Microspheres break out by Type, by Application?